{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:40:25Z","timestamp":1759423225496,"version":"build-2065373602"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.7759\/cureus.93723","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:06:25Z","timestamp":1759421185000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the Values of Endoglin and Soluble Fms-Like Tyrosine Kinase-1\/Placental Growth Factor Ratio Among Women at Risk for Pre-eclampsia: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Smitha","family":"Subramaniam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavithra","family":"Mourouganandane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena","family":"T S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000472","article-title":"Maternal morbidity associated with early-onset and late-onset preeclampsia","volume":"124","author":"Lisonkova S","year":"2014","unstructured":"Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014, 124:771-81. 10.1097\/AOG.0000000000000472","journal-title":"Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos E","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013, 170:1-7. 10.1016\/j.ejogrb.2013.05.005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana S","year":"2022","unstructured":"Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol. 2022, 226:S1019-34. 10.1016\/j.ajog.2020.10.022","journal-title":"Am J Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2022.02.017","article-title":"Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia","volume":"120","author":"Rowson S","year":"2022","unstructured":"Rowson S, Reddy M, De Guingand DL, Langston-Cox A, Marshall SA, da Silva Costa F, Palmer KR. Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia. Placenta. 2022, 120:73-8. 10.1016\/j.placenta.2022.02.017","journal-title":"Placenta"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713916","article-title":"Evaluation of angiogenic factors (PlGF and sFlt-1) in pre-eclampsia diagnosis","volume":"42","author":"S\u00e1 CP","year":"2020","unstructured":"S\u00e1 CP, Jim\u00e9nez MF, Rosa MW, et al.. Evaluation of angiogenic factors (PlGF and sFlt-1) in pre-eclampsia diagnosis. Rev Bras Ginecol Obstet. 2020, 42:697-704. 10.1055\/s-0040-1713916","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.03.034","article-title":"Hypertensive disorders of pregnancy and long-term risk of maternal stroke-a systematic review and meta-analysis","volume":"229","author":"Brohan MP","year":"2023","unstructured":"Brohan MP, Daly FP, Kelly L, McCarthy FP, Khashan AS, Kublickiene K, Barrett PM. Hypertensive disorders of pregnancy and long-term risk of maternal stroke-a systematic review and meta-analysis. Am J Obstet Gynecol. 2023, 229:248-68. 10.1016\/j.ajog.2023.03.034","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5114\/pm.2019.85785","article-title":"Non-obstetric complications in preeclampsia","volume":"18","author":"Pankiewicz K","year":"2019","unstructured":"Pankiewicz K, Szczerba E, Maciejewski T, Fija\u0142kowska A. Non-obstetric complications in preeclampsia. Prz Menopauzalny. 2019, 18:99-109. 10.5114\/pm.2019.85785","journal-title":"Prz Menopauzalny"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CLD.0000000000000088","article-title":"Hypertensive complications of pregnancy: hepatic consequences of preeclampsia through HELLP syndrome","volume":"22","author":"Mei JY","year":"2023","unstructured":"Mei JY, Afshar Y. Hypertensive complications of pregnancy: hepatic consequences of preeclampsia through HELLP syndrome. Clin Liver Dis (Hoboken). 2023, 22:195-9. 10.1097\/CLD.0000000000000088","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren S","year":"2022","unstructured":"Verlohren S, Brennecke SP, Galindo A, et al.. Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2022, 27:42-50. 10.1016\/j.preghy.2021.12.003","journal-title":"Pregnancy Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64127-2","article-title":"Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction","volume":"158","author":"Lyall F","year":"2001","unstructured":"Lyall F, Bulmer JN, Duffie E, Cousins F, Theriault A, Robson SC. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol. 2001, 158:1713-21. 10.1016\/S0002-9440(10)64127-2","journal-title":"Am J Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-024-00268-7","article-title":"History and evolution of blood pressure measurement","volume":"30","author":"Noh SA","year":"2024","unstructured":"Noh SA, Kim HS, Kang SH, Yoon CH, Youn TJ, Chae IH. History and evolution of blood pressure measurement. Clin Hypertens. 2024, 30:9. 10.1186\/s40885-024-00268-7","journal-title":"Clin Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren S","year":"2010","unstructured":"Verlohren S, Galindo A, Schlembach D, et al.. An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010, 202:161.e1-161.e11. 10.1016\/j.ajog.2009.09.016","journal-title":"Am J Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald TM","year":"2022","unstructured":"MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu'u-Lino TJ. Clinical tools and biomarkers to predict preeclampsia. EBioMedicine. 2022, 75:103780. 10.1016\/j.ebiom.2021.103780","journal-title":"EBioMedicine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.05.038","article-title":"Characteristics and severity of preeclampsia in young and elderly gravidas with hypertensive disease","volume":"228","author":"Rymer-Haskel N","year":"2018","unstructured":"Rymer-Haskel N, Schushan-Eisen I, Hass Y, Rahav R, Maayan-Metzger A, Hendler I. Characteristics and severity of preeclampsia in young and elderly gravidas with hypertensive disease. Eur J Obstet Gynecol Reprod Biol. 2018, 228:120-5. 10.1016\/j.ejogrb.2018.05.038","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.175","article-title":"Maternal body mass index, height, and risks of preeclampsia","volume":"25","author":"Sohlberg S","year":"2012","unstructured":"Sohlberg S, Stephansson O, Cnattingius S, Wikstr\u00f6m AK. Maternal body mass index, height, and risks of preeclampsia. Am J Hypertens. 2012, 25:120-5. 10.1038\/ajh.2011.175","journal-title":"Am J Hypertens"},{"key":"ref16","unstructured":"World Health Organization. (2022). Accessed. August 2, 2025: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/indicator-groups\/indicator-group-details\/GHO\/bmi-among-adults."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/14767050701420027","article-title":"The effect of low body mass index on the development of gestational hypertension and preeclampsia","volume":"20","author":"Belogolovkin V","year":"2007","unstructured":"Belogolovkin V, Eddleman KA, Malone FD, et al.. The effect of low body mass index on the development of gestational hypertension and preeclampsia. J Matern Fetal Neonatal Med. 2007, 20:509-13. 10.1080\/14767050701420027","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref18","article-title":"Pre-eclampsia: the role of soluble VEGF receptor-1 and related antiangiogenic factors beyond.","author":"Wathen K","year":"2022","unstructured":"Wathen K. Pre-eclampsia: the role of soluble VEGF receptor-1 and related antiangiogenic factors beyond.. University of Helsinki, Finland; 2022."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20160608","article-title":"A case of severe preeclampsia presenting as acute pulmonary oedema","volume":"5","author":"Sumangala Devi D","year":"2017","unstructured":"Sumangala Devi D, Vijay Kumar B. A case of severe preeclampsia presenting as acute pulmonary oedema. Int J Reprod Contracept Obstet Gynecol. 2017, 5:899-902. 10.18203\/2320-1770.ijrcog20160608","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref20","article-title":"Predicting preeclampsia","volume":"75","author":"O'Brien WF","year":"1990","unstructured":"O'Brien WF. Predicting preeclampsia. Obstet Gynecol. 1990, 75:445-52.","journal-title":"Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S120944","article-title":"Platelet count and platelet indices in women with preeclampsia","volume":"12","author":"AlSheeha MA","year":"2016","unstructured":"AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I. Platelet count and platelet indices in women with preeclampsia. Vasc Health Risk Manag. 2016, 12:477-80. 10.2147\/VHRM.S120944","journal-title":"Vasc Health Risk Manag"},{"key":"ref22","article-title":"Origin and significance of extremely elevated serum alkaline phosphatase activity during normal pregnancy","volume":"17","author":"Safarova A","year":"2007","unstructured":"Safarova A, Bige O, Dogan E, et al.. Origin and significance of extremely elevated serum alkaline phosphatase activity during normal pregnancy. Turkiye Klinikleri J Gynecol Obst. 2007, 17:405-8.","journal-title":"Turkiye Klinikleri J Gynecol Obst"},{"key":"ref23","article-title":"Severe ascites as the primary symptom of fulminant postpartum HELLP syndrome: a case report","volume":"42","author":"Tan A","year":"2015","unstructured":"Tan A, Ma J, Deng X, Tang G. Severe ascites as the primary symptom of fulminant postpartum HELLP syndrome: a case report. Clin Exp Obstet Gynecol. 2015, 42:685-7.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3027363","article-title":"Placental growth factor, soluble fms-like tyrosine kinase 1, soluble endoglin, IL-6, and IL-16 as biomarkers in preeclampsia","volume":"2016","author":"R\u0103dulescu C","year":"2016","unstructured":"R\u0103dulescu C, Bac\u00e2rea A, Hu\u021banu A, Gabor R, Dobreanu M. Placental growth factor, soluble fms-like tyrosine kinase 1, soluble endoglin, IL-6, and IL-16 as biomarkers in preeclampsia. Mediators Inflamm. 2016, 2016:3027363. 10.1155\/2016\/3027363","journal-title":"Mediators Inflamm"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha S","year":"2006","unstructured":"Venkatesha S, Toporsian M, Lam C, et al.. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006, 12:642-9. 10.1038\/nm1429","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076744","article-title":"Literature review: the sFlt1\/PlGF ratio and pregestational maternal comorbidities: new risk factors to predict pre-eclampsia","volume":"24","author":"Karpova NS","year":"2023","unstructured":"Karpova NS, Dmitrenko OP, Budykina TS. Literature review: the sFlt1\/PlGF ratio and pregestational maternal comorbidities: new risk factors to predict pre-eclampsia. Int J Mol Sci. 2023, 24:10.3390\/ijms24076744","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan H","year":"2023","unstructured":"Stepan H, Galindo A, Hund M, Schlembach D, Sillman J, Surbek D, Vatish M. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023, 61:168-80. 10.1002\/uog.26032","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/416794-assessment-of-the-values-of-endoglin-and-soluble-fms-like-tyrosine-kinase-1placental-growth-factor-ratio-among-women-at-risk-for-pre-eclampsia-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:06:28Z","timestamp":1759421188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/416794-assessment-of-the-values-of-endoglin-and-soluble-fms-like-tyrosine-kinase-1placental-growth-factor-ratio-among-women-at-risk-for-pre-eclampsia-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.93723","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}